Results 171 to 180 of about 112,698 (266)

Review of Bleeding as Initial Presentation in Patients with Chronic Myeloid Leukemia. [PDF]

Clin Appl Thromb Hemost
ALTermanini M, Altrmanini O, Al-Mashdali AF, Ahmed A, Saeed S, Mudarres MF, Saeed M, Abdalla E, Soliman D, Singh K, Saied A, Almahmood M, Suliman A, Qasim H, Abuasab T, Haddad F, Yassin M, Fareed S.   +17 more
europepmc   +1 more source

Neoplastic Risk in Patients With Klinefelter Syndrome

Andrology, EarlyView.
ABSTRACT Background Besides gonadal involvement (hypogonadism, male factor infertility, and testicular hypotrophy), patients with Klinefelter syndrome (KS) may suffer from several extra‐gonadic complications, including neoplastic events. Objective The aim of this review is to summarize all major clinical evidence dealing with the association between KS
Andrea Graziani, Giuseppe Grande, Riccardo Selice, Antonella Di Mambro, Alberto Ferlin   +4 more
wiley   +1 more source

Potential utility of PPARγ agonists in targeting chronic myeloid leukemia stem cells. [PDF]

Ann Hematol
Atef B, El-Ashwah S, Saleh LM, Gawish H, Mabed M.   +4 more
europepmc   +1 more source

Identification of Coagulation Phenotypes Using Viscoelastic and Conventional Assays During Veno‐Venous Extracorporeal Membrane Oxygenation: A Hierarchical Clustering Analysis

Artificial Organs, EarlyView.
Hierarchical clustering of viscoelastic and conventional coagulation parameters identified three distinct phenotypes in V‐V ECMO patients, revealing substantial APTT–CK‐R discordance and highlighting the value of TEG‐derived markers for detecting coagulopathy not captured by standard monitoring.
Daisuke Irimada, Yudai Iwasaki, Yusuke Takei, Moe Oyama, Ami Tanaka, Shinichi Yamaguchi, Naoya Kobayashi, Daisuke Konno, Takuya Shiga, Masanori Yamauchi   +9 more
wiley   +1 more source

Mesenchymal stem cells inhibited chronic myeloid leukemia cells in vitro, correlating with oxidative stress. [PDF]

World J Surg Oncol
Zheng Y, Shi C, Chen Y, Lai B, Wu H, Sheng L, Ge Q, Ouyang G, Yan X.   +8 more
europepmc   +1 more source

Macrocytosis as an Early Pharmacodynamic Marker of Imatinib Efficacy in Chronic Myeloid Leukemia. [PDF]

J Clin Med
Yaman F, Pinar IE, Isik S, Yavasoglu F, Gunduz E, Uskudar Teke H, Andic N.   +6 more
europepmc   +1 more source

The association of thrombocytopenia with haematological malignancy

British Journal of Haematology, EarlyView.
This review article discusses the interplay of immune dysregulation, clonality, and immunosuppressive therapies in immune thrombocytopenia and how this links to the risk of misattribution versus the development of haematological malignancy. Unresolved questions and directions for future research are also discussed. Isolated thrombocytopenia is commonly
Abi Vijenthira, Henrik Frederiksen, Michelle Sholzberg   +2 more
wiley   +1 more source

Chronic myeloid leukemia presenting with isolated central nervous system lymphoid blast crisis: A case report. [PDF]

Rare Tumors
Zarama-Valenzuela Á, Arévalo-Zambrano M, Cadena-Andrade Á, Zárate-Mesa A.   +3 more
europepmc   +1 more source

Impact of CD34+ cell dose on outcomes of related allogeneic PBSCT in adult AML patients

British Journal of Haematology, EarlyView.
Summary CD34+ cell dose is believed to impact the outcomes of allogeneic peripheral blood stem cell transplantation (PBSCT), yet the optimal dose remains unclear. We retrospectively reviewed 2407 adult patients with acute myeloid leukaemia who underwent their first related PBSCT between 2000 and 2019.
Yusuke Toda, Tomoyasu Jo, Yasuyuki Arai, Kaito Harada, Masamitsu Yanada, Takahiro Fukuda, Satoshi Yoshihara, Noriko Doki, Naoyuki Uchida, Yasuo Mori, Yuta Hasegawa, Yukio Kondo, Toshiro Kawakita, Tetsuya Eto, Tetsuya Nishida, Masatsugu Tanaka, Makoto Onizuka, Katsuhiro Shono, Masayuki Hino, Tatsuo Ichinohe, Yoshiko Atsuta, Takaaki Konuma   +21 more
wiley   +1 more source

Combined asciminib and olverembatinib in blast-phase chronic myeloid leukemia. [PDF]

Haematologica
Cheng F, Li W.
europepmc   +1 more source